Article
BCOR Mutations Identify a Clinically Aggressive Subset of Pediatric Rhabdomyosarcoma.
Fetal and pediatric pathology - 1 Jan 2026
Yu Lianyuan, He Lejian, Zhang Nan
Abstract excerpt
Background: BCOR mutations occur in about 5% in pediatric rhabdomyosarcoma (RMS), their clinical significance and mechanistic roles remain undefined. This study characterizes BCOR-mutant RMS as a molecularly distinct, high-risk subgroup. Methods: Multimodal analysis of four pediatric embryonal RMS cases with BCOR mutations, integrating histopathology, immunohistochemistry, genomic profiling, and clinical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
